Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System™ in Patients
IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Innova Vascular, Inc. today announced successful early commercial use of the company's Laguna Thrombectomy System™.
- IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Innova Vascular, Inc. today announced successful early commercial use of the company's Laguna Thrombectomy System™.
- The Laguna Thrombectomy System encompasses two devices developed by Innova Vascular: the Malibu Aspiration Catheter™ System and the Laguna Clot Retriever™ System.
- "We are extremely pleased with the early clinical performance of the system and look forward to expanding our product launch in the period ahead," said Sanjay Shrivastava, Ph.D., CEO of Innova Vascular.
- "Successful use of the System marks an important milestone in our commitment to develop innovative technologies targeting large, underserved markets.